Filing Details

Accession Number:
0001181431-12-064463
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-13 16:28:01
Reporting Period:
2012-11-27
Filing Date:
2012-12-13
Accepted Time:
2012-12-13 16:28:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202294 Elliot Sigal Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Evp, Cso & President R&D Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Disposition 2012-11-27 200,630 $0.00 50,158 No 5 G Indirect By Sigal Family Investments, LLC
Common Stock, $0.10 Par Value Acquisiton 2012-11-27 100,315 $0.00 100,315 No 5 G Indirect By C. Elliott Sigal 2012 Irrevocable Trust
Common Stock, $0.10 Par Value Acquisiton 2012-11-27 100,315 $0.00 100,315 No 5 G Indirect By Ruth L. Sigal 2012 Irrevocable Trust
Common Stock, $0.10 Par Value Disposition 2012-12-11 31,451 $33.00 18,707 No 4 S Indirect By Sigal Family Investments, LLC
Common Stock, $0.10 Par Value Disposition 2012-12-11 62,903 $33.00 37,412 No 4 S Indirect By C. Elliott Sigal 2012 Irrevocable Trust
Common Stock, $0.10 Par Value Disposition 2012-12-11 62,903 $33.00 37,412 No 4 S Indirect By Ruth L. Sigal 2012 Irrevocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect By Sigal Family Investments, LLC
No 5 G Indirect By C. Elliott Sigal 2012 Irrevocable Trust
No 5 G Indirect By Ruth L. Sigal 2012 Irrevocable Trust
No 4 S Indirect By Sigal Family Investments, LLC
No 4 S Indirect By C. Elliott Sigal 2012 Irrevocable Trust
No 4 S Indirect By Ruth L. Sigal 2012 Irrevocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.10 Par Value 48,052 Direct
Common Stock, $0.10 Par Value 1,600 Indirect By BMY Savings and Investment Program
Footnotes
  1. On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI.
  2. On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI.
  3. On November 27, 2012, the reporting person's wife contributed her 40% interest in SFI to the Ruth L. Sigal 2012 Irrevocable Trust for the benefit of the reporting person and their children.
  4. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.
  5. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.81 to $33.23, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  6. Based on a plan statement as of the end of the most recent fiscal quarter.